Get started
Author

H. Samonigg

Observed names: H SAMONIGG, H Samonigg, H. SAMONIGG
Observed institutions: University of Vienna, Innsbruck Medical University, University of Graz, Universität Innsbruck, Medical University of Graz, Paracelsus Medical University, Donauspital, Westpfalz Klinikum, Comprehensive Cancer Center Vienna, Wilhelminen Hospital, Graz University Hospital, Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, Hanusch Hospital, Centre Léon Bérard, Universitätsklinik für Frauenheilkunde und Geburtshilfe, Barmherzige Schwestern vom heiligen Kreuz, Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie, Salzburger Landeskliniken, Francis Hospital, Austrian Breast & Colorectal Cancer Study Group, Sandoz Group AG (Switzerland), Universitätsklinikum Wiener Neustadt, Medical University of Vienna, Charité – Universitätsmedizin Berlin
OpenAlex ID: A5111590797
A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
2002 · M.D. Green, H. Koelbl, et al. · Annals of Oncology · 598
Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a
2007 · R. Jakesz, R. Greil, et al. · JNCI Journal of the National Cancer Institute · 311
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
2013 · M Stotz, M Pichler, et al. · British Journal of Cancer · 310
PDF
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
2013 · G Absenger, J Szkandera, et al. · British Journal of Cancer · 223
PDF
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]
1994 · H Ludwig, E Fritz, et al. · Blood · 192
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
2013 · J Szkandera, M Stotz, et al. · British Journal of Cancer · 187
PDF
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.
2001 · P Birner, G Oberhuber, et al. · PubMed · 180
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
2013 · J Szkandera, G Absenger, et al. · British Journal of Cancer · 157
PDF
Extended adjuvant treatment with anastrozole: Results from the Austrian Breast and Colorectal Cancer Study Group Trial 6a (ABCSG-6a)
2005 · R. Jakesz, H. Samonigg, et al. · Journal of Clinical Oncology · 119
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
2021 · D. Miles, E. Ciruelos, et al. · Annals of Oncology · 98
PDF
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
2007 · for the Austrian Breast and Colorectal Cancer Study Group, W Schippinger, et al. · British Journal of Cancer · 98
PDF
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
2012 · M Pichler, E Winter, et al. · British Journal of Cancer · 90
PDF
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
2013 · J Szkandera, A Gerger, et al. · British Journal of Cancer · 84
PDF
Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings
2003 · L. Baider, E. Andritsch, et al. · Critical Reviews in Oncology/Hematology · 77
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
2015 · on behalf of the Austrian Breast and Colorectal Cancer Study group (ABCSG), F Fitzal, et al. · British Journal of Cancer · 74
PDF
In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images
2008 · A. Gerger, R. Hofmann-Wellenhof, et al. · British Journal of Dermatology · 72
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
2013 · R.A. Popescu, R. Schäfer, et al. · Annals of Oncology · 70
PDF
In vivoconfocal laser scanning microscopy in the diagnosis of melanocytic skin tumours
2009 · A. Gerger, R. Hofmann-Wellenhof, et al. · British Journal of Dermatology · 69
Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
1999 · R. Jakesz, H. Hausmaninger, et al. · European Journal of Cancer · 69
P81 Benefits of switching postmenopausal women withhormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3123 women enrolled in the ABCSG Trial 8 and the ARNO 95 Trial
2005 · M. Kaufmann, R. Jakesz, et al. · The Breast · 68
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
2013 · on behalf of the Austrian Breast and Colorectal Cancer Study Group, M Gnant, et al. · British Journal of Cancer · 59
PDF
The use of confocal laser-scanning microscopy in microsurgery for invasive squamous cell carcinoma
2006 · M. Horn, A. Gerger, et al. · British Journal of Dermatology · 47
Do different cultural settings affect the psychological distress of women with breast cancer? A randomized study
2003 · L. BAIDER, E. ANDRITSCH, et al. · European Journal of Cancer Care · 44
PDF
Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival
2012 · T Gary, K Belaj, et al. · British Journal of Cancer · 42
PDF
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients
2013 · A.C. Regierer, R. Wolters, et al. · Annals of Oncology · 40
PDF
Works count: 134
Citation count: 4,089
H-index: 30
I10-index: 53
Year
Topic
Type